1.Lacour, J, Bucalossi, P, Caceres, Eet al. Radical mastectomy versus radical mastectomy plus internal mammary dissection: five-year results of an international cooperative study. Cancer 1976; 37: 206–214.
2.Livingston, S F, Arlen, M. The extended extrapleural radical mastectomy: its role in the treatment of carcinoma of the breast. Ann Surg 1974; 179: 260–265.
3.Urban, J A, Marjani, M A. Significance of internal mammary lymph node metastases in breast cancer. Am J Roentgenol Radium Ther Nucl Med 1971; 3: 130–136.
4.Ca’ceres, E. An evaluation of radical mastectomy and extended radical mastectomy for cancer of the breast. Surg Gynecol Obstet 1967; 125: 337–341.
5.Donegan, W L. The influence of untreated internal mammary metastases upon the course of mammary cancer. Cancer 1977; 39: 533–538.
6.Handley, R S. Carcinoma of the breast. Ann R Coll Surg Engl 1975; 57: 59–66.
7.Overgaard, M, Hansen, P S, Overgaard, Jet al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish breast cancer cooperative group 82b trial. N Engl J Med 1997; 337: 949–955.
8.Ragaz, J, Jackson, S M, Le, Net al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997; 337: 956–962.
9.Buchholz, T. Internal mammary lymph nodes: to treat or not to treat. Int J Rad Oncol Biol Phys 2000; 46: 801–803.
10.Freedman, G, Fowble, B L, Nicolaou, Net al. Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? Int J Rad Oncol Biol Phys 2000; 46: 805–814.
11.Marks, L, Hebert, M E, Bentel, G, Spencer, D P, Sherouse, G W, Prosnitz, L R. To treat or not to treat the internal mammary nodes: a possible compromise. Int J Radiat Oncol Biol Phys 1994; 29: 903–909.
12.Taghian, A, Jagsi, R, Makris, Aet al. Results of a survey regarding irradiation of internal mammary chain in patients with breast cancer: practice is culture driven rather than evidence based. Int J Radiat Oncol Biol Phys 2004; 60: 706–714.
13.Cuzick, J, Stewart, H, Rutqvist, Let al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 1994; 12: 447–453.
14.Chung, E, Corbett, J R, Moran, J Met al. Is there a dose-response relationship for heart disease with low-dose radiation therapy? Int J Radiat Oncol Biol Phys 2013; 85: 959–964.
15.Haris, E E, Correa, C, Hwang, W Tet al. Late cardiac mortality and morbidity in early-stage breast cancer patients after breast conservation treatment. J Clin Oncol 2006; 24: 4100–4106.
16.Hooning, M J, Botma, A, Aleman, B Met al. Long term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst 2007; 99: 365–375.
17.Darby, S C, McGale, P, Taylor, C W, Peto, R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 2005; 6: 557–565.
18.Darby, S C, Evertz, M, McGale, Pet al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013; 368: 987–998.
19.Goldhirsch, A, Piccart-Gebhart, MJ, Procter, Met al. HERA trial: 2 years versus 1 year of trastuzumab after adjuvant chemotherapy in women with HER2-positive early breast cancer at 8 years of median follow up. Abstract #LBA6. ESMO, 2012.
20.Mamounas, E P, Bryant, J, Lembersk, Bet al. Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28. J Clin Oncol 2005; 23: 3686–3696.
21.Chang, J S, Park, W, Kim, Y Bet al. Long-term survival outcomes following internal mammary node irradiation in stage II-III breast cancer: results of a large retrospective study with 12-year follow-up. Int J Radiat Oncol Biol Phys 2013; 86: 867–872.
22.Poortmans, P S H, Kirkove, C, Budach, Vet al. Irradiation of the internal mammary and medial supraclavicular lymph nodes in stage I to III breast cancer: 10 years results of the EORTC radiation oncology and breast cancer groups phase III trial 22922/10925. EJC 2013; 47 (suppl 2).
23.Hindie´, E, Groheux, D, Hennequin, Cet al. Lymphoscintigraphy can select breast cancer patients for internal mammary chain radiotherapy. Int J Radiat Oncol Biol Phys 2012; 83: 1081–1088.
24.RTOG/EORTC working group. LENT SOMA scales for all anatomic sites. Int J Radiat Oncol Biol Phys 1995; 31 (5): 1049–1091.
25.Hennequin, C, Bossard, N, Servagi-Vernat, Set al. Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy. Int J Radiat Oncol Biol Phys 2013; 86: 860–866.
26.Whelan, TJOI, Ackerman, I, Chapman, J Wet al. NCIC-CTG MA.20: an intergroup trial of regional nodal irradiation in early breast cancer. J Clin Oncol 2011; 29 (suppl 18): LBA1003.
27.Budach, W, Kammers, K, Boelke, E, Matuschek, C. Adjuvant radiotherapy of regional lymph nodes in breast cancer – a meta-analysis of randomized trials. Radiat Oncol 2013; 8: 267.
28.Olson, R A, Woods, R, Speers, Cet al. Does the intent to irradiate the internal mammary nodes impact survival in women with breast cancer? A population based analysis in British Columbia. Int J Radiat Oncol Biol Phys 2012; 83: e35–e41.
29.Chung, Y, Suh, C, Cho, Y, Lee, J, Kim, Y. Dummy run study of quality assurance program in KROG 0806 study, phase 3 randomized trial to investigate the role of internal mammary lymph node irradiation for breast cancer patients. Int J Radiat Oncol Biol Phys 2014; 90: S255, abstract no. 2097.